Showing results (31-40 of 407) with videos related to

Sort By:
Pageof 41
Clinical Neuropharmacology|April 7, 2007
Effects of pharmacological therapy on gait and cognitive function in depressed patientsDiana Paleacu, Agatha Shutzman, Nir Giladi, et al.
Gait & Posture|August 8, 2009
Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carersAlice Nieuwboer, Lynn Rochester, Talia Herman, et al.
Neurorehabilitation and Neural Repair|June 19, 2013
Does the evaluation of gait quality during daily life provide insight into fall risk? A novel approach using 3-day accelerometer recordingsAner Weiss, Marina Brozgol, Moran Dorfman, et al.
Drugs in R&D|April 12, 2014
Effect of rivastigmine on mobility of patients with higher-level gait disorder: a pilot exploratory studyTanya Gurevich, Yacov Balash, Doron Merims, et al.
Expert Review of Neurotherapeutics|July 5, 2011
The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?Orit Segev-Jacubovski, Talia Herman, Galit Yogev-Seligmann, et al.
Journal of Neurology|August 3, 2015
Fall risk is associated with amplified functional connectivity of the central executive network in patients with Parkinson's diseaseKeren Rosenberg-Katz, Talia Herman, Yael Jacob, et al.
Medical Engineering & Physics|November 28, 2009
Can an accelerometer enhance the utility of the Timed Up & Go Test when evaluating patients with Parkinson's disease?Aner Weiss, Talia Herman, Meir Plotnik, et al.
Pageof 41